Clinical Trial Update: Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of immunotherapy with autologous hematopoietic stem cell transplant and CD22/CD19 CAR-T cells for B-cell acute l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD22/CD19 CAR-T cells (CD22/CD19 CAR-T cells)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Lymphobkastic Leukemia | Phase 2 | Status: NOT_YET_RECRUITING